The New Germany Fund, Inc. (GF)
Chart Events
Performance Outlook
| Previous Close | 8.88 |
| Open | 8.92 |
| Bid | 8.29 x 1000 |
| Ask | 8.88 x 800 |
| Day's Range | 8.86 - 9.02 |
| 52 Week Range | 7.64 - 21.37 |
| Volume | |
| Avg. Volume | 18,819 |
| Market Cap | 151.842M |
| Beta (5Y Monthly) | 1.21 |
| PE Ratio (TTM) | 15.28 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.66 (18.93%) |
| Ex-Dividend Date | May 13, 2022 |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for GF
Related Research
- New Germany Fund, Inc. (The)Analyst Report: Dr. Reddy's Laboratories LimitedHeadquartered in India, Dr. Reddy’s Laboratories develops and manufactures generic pharmaceutical products sold across the world. The company specializes in low-cost, easy-to-produce small-molecule generic drugs and active pharmaceutical ingredients. Its drug portfolio in recent years has included biosimilar drug launches in select emerging markets and has shifted toward injectables and more complex generic products. Geographically, the company’s sales are well dispersed across North America, India, and other emerging markets.RatingFair ValueEconomic Moat6 days agoMorningstar
- Business Wire
The Central and Eastern Europe Fund, Inc., The European Equity Fund, Inc., and The New Germany Fund, Inc. Announce Extension of Share Repurchases
NEW YORK, July 29, 2022--The Central and Eastern Europe Fund, Inc. (NYSE: CEE), The European Equity Fund, Inc. (NYSE: EEA), and The New Germany Fund, Inc. (NYSE: GF) (each, a "Fund," and collectively, the "Funds") each announced today that its Board of Directors has approved an extension of the current repurchase authorization permitting CEE, EEA, GF and to repurchase up to 622,066, 708,104 and 1,756,928 shares, respectively (representing approximately 10% of each Fund’s current shares outstandi
- Business Wire
The Central and Eastern Europe Fund, Inc. and The New Germany Fund, Inc. Announce Results of Each Fund’s Annual Meeting of Stockholders
NEW YORK, June 23, 2022--The Central and Eastern Europe Fund, Inc. (NYSE: CEE) and The New Germany Fund, Inc. (NYSE: GF) (each, a "Fund," and, collectively, the "Funds") announced today the results of their Joint Annual Meetings of Stockholders held on June 23, 2022.
- Business Wire
The New Germany Fund, Inc. Announces Portfolio Manager Change
NEW YORK, May 26, 2022--The New Germany Fund, Inc. (NYSE: GF) (the "Fund") announced today that Leon Cappel will replace Philipp Schweneke as the Fund’s deputy portfolio manager effective June 1, 2022. Valerie Schuler will continue to serve as the Fund’s portfolio manager.
